Stryker stock is trading -13.71% below its average target price of $429.26 after dropping -1.3% during today's afternoon session. Analysts are giving the Large-Cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $316.0 to $465.0 per share.
Stryker's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.3%. The stock's short ratio is 4.52. The company's insiders own 5.36% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 82.0%. In conclusion, we believe there is positive market sentiment regarding Stryker.
Institutions Invested in Stryker
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 9% | 33,500,571 | $12,408,946,626 |
| 2025-06-30 | Blackrock Inc. | 7% | 26,626,621 | $9,862,766,782 |
| 2025-06-30 | Greenleaf Trust | 4% | 16,689,224 | $6,181,855,522 |
| 2025-06-30 | State Street Corporation | 4% | 14,956,732 | $5,540,123,154 |
| 2025-06-30 | JPMORGAN CHASE & CO | 3% | 12,228,473 | $4,529,548,728 |
| 2025-06-30 | Price (T.Rowe) Associates Inc | 3% | 11,898,494 | $4,407,321,206 |
| 2025-06-30 | Geode Capital Management, LLC | 2% | 7,393,611 | $2,738,667,477 |
| 2025-06-30 | FMR, LLC | 2% | 7,153,153 | $2,649,599,428 |
| 2025-06-30 | Capital Research Global Investors | 2% | 6,766,607 | $2,506,418,923 |
| 2025-06-30 | Morgan Stanley | 2% | 6,220,256 | $2,304,045,047 |
